A phase 1/2 trial of a novel viral vector gene therapy in adults with type 1 diabetes is scheduled to begin this year.

Irvine-based biotech company Eledon Pharmaceutical announced updated data from its islet cell transplant study.

Type 1 diabetes researchers have made great progress in understanding the disease in the last two decades, even as a cure ...

Measles, mumps, and polio are things we can prevent with vaccines, but scientists are looking to add a surprising entry to ...

How Does Tzield Work in Type 1 Diabetes? Type 1 diabetes is an autoimmune disease in which your immune system mistakenly attacks and damages the beta cells in your pancreas. The beta cells produce ...

In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated ...

There’s a cliché in the type 1 diabetes community that a cure has been “five years away” for as long as anyone can remember. For decades, patients have been told that researchers were on the verge of ...

Once known as “juvenile” diabetes, type 1 diabetes was long considered a childhood disease. Although the condition is often diagnosed in children and teenagers, it can develop at any age. Type 1 ...

A lawsuit alleges that the state’s prisons limit access to insulin pumps and glucose monitors, putting people with Type 1 ...